The human Philadelphia chromosome (Ph) is present in over 95% of CML cases [1], and arises from a reciprocal translocation between chromosome 9 and 22, resulting in the formation of the chimeric BCR-ABL oncogene. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.